MX2013005726A - Composicion que comprende proteinas hidrolizadas y oligosacaridos para tratar enfermedades de la piel. - Google Patents

Composicion que comprende proteinas hidrolizadas y oligosacaridos para tratar enfermedades de la piel.

Info

Publication number
MX2013005726A
MX2013005726A MX2013005726A MX2013005726A MX2013005726A MX 2013005726 A MX2013005726 A MX 2013005726A MX 2013005726 A MX2013005726 A MX 2013005726A MX 2013005726 A MX2013005726 A MX 2013005726A MX 2013005726 A MX2013005726 A MX 2013005726A
Authority
MX
Mexico
Prior art keywords
composition
skin diseases
oligosaccharides
hydrolysed proteins
treating skin
Prior art date
Application number
MX2013005726A
Other languages
English (en)
Other versions
MX343322B (es
Inventor
Norbert Sprenger
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43733345&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2013005726(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013005726A publication Critical patent/MX2013005726A/es
Publication of MX343322B publication Critical patent/MX343322B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

La invención describe una composición que comprende al menos una N-acetil lactosamina, al menos un oligosacárido sialilado y al menos un oligosacárido fucosilado, y un hidrolizado que comprende proteínas parcialmente y/o completamente hidrolizadas, para ser usada en la prevención y/o tratamiento de condiciones de la piel y enfermedades de la piel. Preferentemente, dicha composición es una fórmula infantil de inicio. Dicha enfermedad de la piel en particular es dermatitis atópica.
MX2013005726A 2010-11-23 2011-11-21 Composicion que comprende proteinas hidrolizadas y oligosacaridos para tratar enfermedades de la piel. MX343322B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10192229A EP2465508A1 (en) 2010-11-23 2010-11-23 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
PCT/EP2011/070562 WO2012076322A1 (en) 2010-11-23 2011-11-21 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases

Publications (2)

Publication Number Publication Date
MX2013005726A true MX2013005726A (es) 2013-07-03
MX343322B MX343322B (es) 2016-11-01

Family

ID=43733345

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013005726A MX343322B (es) 2010-11-23 2011-11-21 Composicion que comprende proteinas hidrolizadas y oligosacaridos para tratar enfermedades de la piel.

Country Status (16)

Country Link
US (1) US10391141B2 (es)
EP (2) EP2465508A1 (es)
CN (1) CN103442717A (es)
AU (1) AU2011340881B2 (es)
BR (1) BR112013012132A2 (es)
CA (1) CA2817122A1 (es)
CL (1) CL2013001471A1 (es)
ES (1) ES2620260T3 (es)
IL (1) IL226127A0 (es)
MX (1) MX343322B (es)
PH (1) PH12013500876A1 (es)
PL (1) PL2643005T3 (es)
RU (1) RU2586776C2 (es)
SG (1) SG190171A1 (es)
TW (1) TW201240607A (es)
WO (1) WO2012076322A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2465509A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
MX2013007692A (es) 2010-12-31 2013-08-15 Abbott Lab Metodos para disminuir la incidencia de la enterocolitis necrotizante en bebes, infantes, o niños al usar los oligosacaridos de leche humana.
MX338174B (es) 2010-12-31 2016-04-06 Abbott Lab Metodos para reducir la incidencia de la tension oxidativa al usar los oligosacaridos de leche humana, la vitamina c y los agentes antiinflamatorios.
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
ES2657744T3 (es) 2011-07-22 2018-03-06 Abbott Laboratories Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal
MX368124B (es) 2011-08-29 2019-09-19 Abbott Lab Oligosacaridos de leche humana para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
JP2015512936A (ja) * 2012-04-13 2015-04-30 トラスティーズ オブ ボストン カレッジ プレバイオティクス組成物およびその使用方法
US20160113952A1 (en) * 2013-05-22 2016-04-28 Glycom As Synthetic Mixture of Oligosaccharides for Treating a Microbiota of a Mammal
US10758555B2 (en) * 2013-11-15 2020-09-01 Societe Des Produits Nestle S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by C-section
US10568896B2 (en) 2013-11-19 2020-02-25 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
SG11201608248YA (en) 2014-04-08 2016-10-28 Abbott Lab Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
WO2016013928A1 (en) * 2014-07-24 2016-01-28 N.V. Nutricia Prevention or treatment of food allergy in infants and toddlers
AU2015340652B9 (en) 2014-10-31 2020-04-16 Société des Produits Nestlé S.A. Composition comprising Fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
ES2772685T3 (es) * 2015-08-04 2020-07-08 Nestle Sa Composiciones nutricionales con 2FL y LNNT para inducir una microbiota intestinal similar a la de los bebés lactantes
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
AU2017213082B2 (en) * 2016-01-26 2021-07-01 Société des Produits Nestlé S.A. Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
CN108495562A (zh) * 2016-01-26 2018-09-04 雀巢产品技术援助有限公司 具有特异性低聚糖的用于预防或治疗变态反应的组合物
CN108495560A (zh) * 2016-01-26 2018-09-04 雀巢产品技术援助有限公司 用于预防和/或治疗皮肤病症和皮肤疾病的组合物
SG10202100843TA (en) 2016-07-28 2021-03-30 Fonterra Cooperative Group Ltd Dairy product and process
CN110650635A (zh) * 2017-05-24 2020-01-03 雀巢产品有限公司 出于健康目的而用于婴儿或幼儿的hmo共混物
US11524019B2 (en) 2017-08-21 2022-12-13 Glycom A/S Synthetic composition for reducing allergy symptoms
CN108935697A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种用于预防小儿湿疹的营养组合物
US20220062161A1 (en) * 2018-12-19 2022-03-03 Societe Des Produits Nestle S.A. Composition for preventing or reducing transepidermal water loss and improving skin barrier function
BR112022005058A2 (pt) * 2019-10-17 2022-06-21 Nestle Sa Fórmula para bebês extensamente hidrolisada
EP4084628A1 (en) * 2019-12-30 2022-11-09 Société des Produits Nestlé S.A. Infant formula
CN114009510A (zh) * 2021-11-24 2022-02-08 北安宜品努卡乳业有限公司 一种低致敏性婴儿羊乳基配方乳粉及其制备方法
CN114128767B (zh) * 2021-11-30 2023-12-22 内蒙古伊利实业集团股份有限公司 含有母乳低聚糖的乳蛋白部分水解低致敏性婴儿配方食品

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
EP0827697B1 (fr) 1996-09-06 2002-06-12 Societe Des Produits Nestle S.A. Induction de la tolérance au lait de vache
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
EP1032364B1 (en) * 1998-07-27 2004-03-03 E-L Management Corp. Topical compositions containing sialyl sugars and their derivatives
FR2853978B1 (fr) * 2003-04-16 2006-02-03 Eurocopter France Procede et dispositif de securisation du vol d'un aeronef en conditions de vol aux instruments hors infrastructures de vol aux instruments
ES2314461T3 (es) * 2003-10-24 2009-03-16 N.V. Nutricia Composicion simbiotica para bebes.
CA2548140A1 (en) * 2003-12-05 2005-06-23 University Of Massachusetts Oligosaccharide compositions and use thereof in the treatment of infection
US8314061B2 (en) 2006-01-09 2012-11-20 Children's Hospital Medical Center Adiponectin for treatment of various disorders
CN101432007A (zh) * 2006-03-07 2009-05-13 雀巢产品技术援助有限公司 合益素混合物
PL1993577T3 (pl) * 2006-03-10 2014-07-31 Nutricia Nv Stosowanie nieulegających trawieniu sacharydów dla zapewnienia niemowlęciu najlepszego startu po narodzinach
WO2007114683A1 (en) * 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
US20070291440A1 (en) 2006-06-15 2007-12-20 Dueber Thomas E Organic encapsulant compositions based on heterocyclic polymers for protection of electronic components
DK2164349T3 (en) * 2006-08-04 2014-12-15 Shs Int Ltd protein-FORMULA
GB0618000D0 (en) * 2006-09-13 2006-10-18 Environment Agency The Fluid sampling device
NL1032840C2 (nl) * 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
EP2044851A1 (en) * 2007-09-26 2009-04-08 Nestec S.A. Prevention of allergy at weaning
CA2705145A1 (en) 2007-11-07 2009-05-14 Mead Johnson Nutrition Company Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas
CN101909636A (zh) 2007-11-08 2010-12-08 雀巢产品技术援助有限公司 包含n-乙酰基乳糖胺的寡糖用于使新生儿免疫应答成熟的应用
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
CN102123715B (zh) * 2008-06-13 2014-12-17 N.V.努特里奇亚 刺激免疫系统的营养物
WO2010064930A1 (en) * 2008-11-28 2010-06-10 Julian Crane Use of lactic acid bacteria to treat or prevent eczema

Also Published As

Publication number Publication date
CL2013001471A1 (es) 2014-01-24
MX343322B (es) 2016-11-01
BR112013012132A2 (pt) 2016-09-27
IL226127A0 (en) 2013-06-27
US20130243797A1 (en) 2013-09-19
TW201240607A (en) 2012-10-16
EP2465508A1 (en) 2012-06-20
CN103442717A (zh) 2013-12-11
CA2817122A1 (en) 2012-06-14
AU2011340881B2 (en) 2016-09-29
PH12013500876A1 (en) 2013-07-01
EP2643005B1 (en) 2017-03-01
WO2012076322A1 (en) 2012-06-14
US10391141B2 (en) 2019-08-27
RU2586776C2 (ru) 2016-06-10
ES2620260T3 (es) 2017-06-28
AU2011340881A1 (en) 2013-05-23
EP2643005A1 (en) 2013-10-02
RU2013128573A (ru) 2014-12-27
SG190171A1 (en) 2013-06-28
PL2643005T3 (pl) 2017-08-31

Similar Documents

Publication Publication Date Title
MX2013005726A (es) Composicion que comprende proteinas hidrolizadas y oligosacaridos para tratar enfermedades de la piel.
MY160894A (en) Oligosaccharide composition for treating skin diseases
MX343321B (es) Composicion para ser usada en la prevencion de infecciones agudas del tracto respiratorio y/o para aliviar los sintomas de dichas infecciones.
PH12016500762A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
NZ601148A (en) Use of pentosan polysulfate for treatment or prophylaxis of allergic rhinitis
WO2012112777A3 (en) Biosynthesis of human milk oligosaccharides in engineered bacteria
WO2009040445A3 (en) Arabinoxylo-oligosaccharides useful against gastrointestinal infections
MX2012005151A (es) Tratamiento de hemoglobinuria nocturna paroxismica, anemias hemoliticas y estados de enfermedad que involucran hemolisis intravascular y extravascular.
MY184985A (en) Oligosaccharide mixture and food product comprising this mixture, especially infant formula
WO2009092383A3 (en) Products and methods to prevent infection
NZ612504A (en) Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
MX2013011835A (es) Composiciones nutricionales que incluyen acidos grasos de cadena ramificada para la curacion de heridas.
IN2012DN00624A (es)
WO2010023422A8 (en) Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation
WO2008096203A3 (en) Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders
MY150931A (en) Substituted oxazolidinones and their use
MX2012007166A (es) Composicion antiviral sinergica y su uso.
UA100011C2 (ru) Применение хитозанов для нетерапевтического способа ускорения скорости роста ногтей
WO2011136573A3 (ko) 비만 치료 및 항산화 활성을 갖는 효모 가수분해물
GB201200858D0 (en) Prebiotic powder composition and uses thereof
WO2011044523A3 (en) Compositions and methods for treating obesity
ATE509532T1 (de) Essbare prdoukte
EP2005194A4 (en) HEMOGLOBIN-BASED METHODS FOR PROPHYLAXIS, DIAGNOSTIC OR BZW. TREATMENT OF NETWORK DISEASES
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
WO2010042212A3 (en) Methods for treating or preventing pain using spicamycin derivatives

Legal Events

Date Code Title Description
FG Grant or registration